Literature DB >> 29600108

Hydroxychloroquine-induced cardiomyopathy and heart failure in twins.

Hang Zhao1,2, Joyce Wald1, Michael Palmer3, Yuchi Han1.   

Abstract

Hydroxychloroquine (HCQ)-induced cardiomyopathy is one of the rare but severe complications following prolonged HCQ use. However, the exact mechanism of HCQ cardiotoxicity remains unclear and it is difficult to identify risk factors. We present a case of twin sisters who both suffered from systemic lupus erythematosus (SLE) and HCQ-induced cardiomyopathy presenting with decompensated heart failure (HF), suggesting that genetic predisposition might be a factor in HCQ-induced cardiomyopathy.

Entities:  

Keywords:  Hydroxychloroquine (HCQ); cardiomyopathy; heart failure (HF); twins

Year:  2018        PMID： 29600108      PMCID： PMC5863196          DOI： 10.21037/jtd.2017.12.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  8 in total

1.  Hydroxychloroquine: a treatable cause of cardiomyopathy.

Authors:  Siddique Abbasi; Laura Tarter; Ramin Farzaneh-Far; Afshin Farzaneh-Far
Journal:  J Am Coll Cardiol       Date:  2012-08-21       Impact factor: 24.094

2.  [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].

Authors:  A Saussine; M-A Loriot; C Picard; V Lecerf; J Landry; I Scheer; S Voicu; A Leenhardt; G Ducrocq; E Maubec; B Crickx
Journal:  Ann Dermatol Venereol       Date:  2009-06-02       Impact factor: 0.777

Review 3.  Chloroquine cardiomyopathy - a review of the literature.

Authors:  Ernst Tönnesmann; Reinhard Kandolf; Thorsten Lewalter
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-05-01       Impact factor: 2.730

Review 4.  Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.

Authors:  Haran Yogasundaram; Brendan N Putko; Julia Tien; D Ian Paterson; Bibiana Cujec; Jennifer Ringrose; Gavin Y Oudit
Journal:  Can J Cardiol       Date:  2014-08-23       Impact factor: 5.223

5.  Fatal antimalarial-induced cardiomyopathy: report of 2 cases.

Authors:  Morteza Azimian; Sakir H Gultekin; Jessica L Hata; James B Atkinson; Kim A Ely; Howard A Fuchs; Bret C Mobley
Journal:  J Clin Rheumatol       Date:  2012-10       Impact factor: 3.517

6.  New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.

Authors:  T Rinda Soong; Lili A Barouch; Hunter C Champion; Frederick M Wigley; Marc K Halushka
Journal:  Hum Pathol       Date:  2007-12       Impact factor: 3.466

7.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

8.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

Authors:  Holger Vogelsberg; Heiko Mahrholdt; Claudia C Deluigi; Ali Yilmaz; Eva M Kispert; Simon Greulich; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094
  8 in total
  11 in total

1.  Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery.

Authors:  Gülendam Koçak; Yakup Ergul; Kemal Nişli; Ali Can Hatemi; Ercan Tutar; Niyazi Kürşad Tokel; Ahmet Celebi
Journal:  Anatol J Cardiol       Date:  2020-07       Impact factor: 1.596

Review 2.  Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?

Authors:  Partha Palit; Debprasad Chattopadhyay; Sabu Thomas; Amit Kundu; Hyung Sik Kim; Nima Rezaei
Journal:  Phytomedicine       Date:  2020-10-28       Impact factor: 5.340

Review 3.  Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

Authors:  Romain Muller
Journal:  Rheumatol Int       Date:  2021-04-24       Impact factor: 2.631

4.  Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.

Authors:  Yanting Yu; Jianteng Xu; Anni Xie; Sijia Liu; Xiaojian Wang; Runzhang Zhu; Xiaoyan Wang
Journal:  Kidney Dis (Basel)       Date:  2021-04-19

Review 5.  Hydroxychloroquine in COVID-19 Patients: Pros and Cons.

Authors:  Nour K Younis; Rana O Zareef; Sally N Al Hassan; Fadi Bitar; Ali H Eid; Mariam Arabi
Journal:  Front Pharmacol       Date:  2020-11-19       Impact factor: 5.810

6.  A large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction.

Authors:  Adarsh Singh; Riddhiman Dhar
Journal:  J Biomol Struct Dyn       Date:  2021-05-17

Review 7.  Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.

Authors:  Alina Dima; Ciprian Jurcut; François Chasset; Renaud Felten; Laurent Arnaud
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-02-14       Impact factor: 5.346

Review 8.  Nanomedicine strategies to target coronavirus.

Authors:  Marcel Alexander Heinrich; Byron Martina; Jai Prakash
Journal:  Nano Today       Date:  2020-08-31       Impact factor: 18.962

9.  Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity.

Authors:  Amanda Chang; Gabriel Stolin; Judith Fan; Boris R Larreta; Gregory A Fishbein; William Dean Wallace; Arnold S Baas; Daniel Cruz; Jessica Wang
Journal:  ESC Heart Fail       Date:  2019-09-07

10.  Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.

Authors:  Chandu Sadasivan; Josie T Y Chow; Bun Sheng; David K H Chan; Yiting Fan; Paul C L Choi; Jeffrey K T Wong; Mabel M B Tong; Tsz-Ngai Chan; Erik Fung; Kevin K H Kam; Joseph Y S Chan; Wai-Kin Chi; D Ian Paterson; Manohara Senaratne; Neil Brass; Gavin Y Oudit; Alex P W Lee
Journal:  PLoS One       Date:  2020-09-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.